AFLAC Incorporated (AFL) was Resumed by Wells Fargo to “Market Perform”. Wells Fargo advised their investors in a research report released on Sep 23, 2016.
On the company’s financial health, AFLAC Incorporated reported $1.71 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $1.68. The company had revenue of $5437.00 million for the quarter, compared to analysts expectations of $5469.99 million. The company’s revenue was up 2.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.50 EPS.
AFLAC Incorporated opened for trading at $73.69 and hit $73.95 on the upside on Thursday, eventually ending the session at $73.52, with a gain of 0.03% or 0.02 points. The heightened volatility saw the trading volume jump to 14,77,723 shares. Company has a market cap of $30,112 M.
In a different news, on Sep 14, 2016, Audrey B Tillman (Executive Vice President) sold 18,856 shares at $73.50 per share price. According to the SEC, on Sep 2, 2016, Teresa L White (President, Aflac U.S.) sold 35,734 shares at $74.28 per share price. On Aug 15, 2016, Koji Ariyoshi (Exec.VP – Aflac Japan) sold 57,413 shares at $73.20 per share price, according to the Form-4 filing with the securities and exchange commission.
Aflac Incorporated (Aflac) is a business holding company. The Company is engaged in supplemental health and life insurance which is marketed and administered through its subsidiary American Family Life Assurance Company of Columbus (Aflac). Aflac offers insurance policies in Japan and the United States that provide a layer of financial protection against income and asset loss. Aflac’s insurance business consists of two segments: Aflac Japan and Aflac U.S. Aflac Japan sells voluntary supplemental insurance products including cancer plans medical indemnity plans medical/sickness riders care plans living benefit life plans ordinary life insurance plans and annuities. Aflac U.S. sells insurance products including products designed to protect individuals from depletion of assets such as accident cancer critical illness/care hospital intensive care hospital indemnity fixed-benefit dental and vision care plans and loss-of-income products.